Lumida
/INO
⌘K
Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc

INO
$1.25USD-2.34%-0.03 today

MARKET CAP

129.2M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.8M$10.3M$832,010$217,756$65,343
YoY %-76.1%+478.2%-91.9%-73.8%-70.0%
P / Sales587.2x35.3x180.4x228.3x1248.5x
EV / Sales601.3x43.1x227.6x131.3x1339.4x
Gross Profit, Adj.$1.8M$10.3M$832,010$217,756$65,343
YoY %-76.1%+478.2%-91.9%-73.8%-70.0%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit601.3x43.1x227.6x131.3x1339.4x
EBITDA, Adj.$-296.5M$-262.1M$-130.7M$-110.6M$-85.4M
YoY %-146.1%+11.6%+50.1%+15.3%+22.8%
Margin %-16705.8%-2553.8%-15704.1%-50812.3%-130701.4%
EV / EBITDA-3.6x-1.7x-1.4x-0.3x-1.0x
EBIT$-301.2M$-267.6M$-143.9M$-112.4M$-86.8M
YoY %-142.8%+11.2%+46.2%+21.9%+22.8%
Margin %-16972.3%-2607.4%-17300.3%-51616.9%-132871.3%
EV / EBIT-3.5x-1.7x-1.3x-0.3x-1.0x
Net Income$-303.7M$-279.8M$-135.1M$-107.3M$-84.9M
YoY %-82.5%+7.9%+51.7%+20.6%+20.8%
Net Margin-17109.9%-2726.7%-16239.9%-49254.3%-130000.0%
EPS (GAAP)-$17.45-$14.07-$6.09-$3.95-$1.81
YoY %-35.9%+19.4%+56.7%+35.1%+54.2%